journal article·2021-10-08Open access

Polyamide/Poly(Amino Acid) Polymers for Drug Delivery

Sai H. S. Boddu, Prakash Bhagav, Pradeep K. Karla, Shery Jacob, Mansi D. Adatiya, Tejas M. Dhameliya, Ketan M. Ranch, Amit K. Tiwari

Abstract

Polymers have always played a critical role in the development of novel drug delivery systems by providing the sustained, controlled and targeted release of both hydrophobic and hydrophilic drugs. Among the different polymers, polyamides or poly(amino acid)s exhibit distinct features such as good biocompatibility, slow degradability and flexible physicochemical modification. The degradation rates of poly(amino acid)s are influenced by the hydrophilicity of the amino acids that make up the polymer. Poly(amino acid)s are extensively used in the formulation of chemotherapeutics to achieve selective delivery for an appropriate duration of time in order to lessen the drug-related side effects and increase the anti-tumor efficacy. This review highlights various poly(amino acid) polymers used in drug delivery along with new developments in their utility. A thorough discussion on anticancer agents incorporated into poly(amino acid) micellar systems that are under clinical evaluation is included.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Biopolymer Synthesis and Applications · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman P.O. Box 346, United Arab Emirates

Center of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman P.O. Box 346, United Arab Emirates

Advanced Drug Delivery Research and Development, Sampann Research and Development, Panacea Biotec Ltd., Ambala, Chandigarh Highway, Lalru 140501, India

Department of Pharmaceutical Sciences, College of Pharmacy, Howard University, 2300 4th St. N.W., Washington, DC 20059, USA

Department of Pharmaceutical Sciences, College of Pharmacy, Gulf Medical University, Ajman 4184, United Arab Emirates

Lallubhai Motilal College of Pharmacy, Navrangpura, Ahmedabad 380009, India

Department of Pharmacology & Experimental Therapeutics, Health Science Campus, The University of Toledo, 3000 Arlington Ave., Toledo, OH 43614, USA

References (100+)

Show source-provided references
1. Polymers for Drug Delivery Systems10.1146/annurev-chembioeng-073009-100847 ↗
2. Drug delivery from nonpeptidic α-amino acid containing polyamides10.1007/s002890050069 ↗
3. Current development of biodegradable polymeric materials for biomedical applications10.2147/DDDT.S165440 ↗
4. Erasure of the processing effects in polyamide 6 based cast films by the introduction of montmorillonite: Effect on water and oxygen transport properties10.1016/j.memsci.2014.01.018 ↗
5. Polyamides and their functionalization: Recent concepts for their applications as biomaterials10.1039/C7BM00160F ↗
6. Grumezescu, A.M., and Holban, A.M. (2018). Chapter 12—Microbial Polyamino Acids: An Overview for Commercial Attention. Role of Materials Science in Food Bioengineering, Academic Press.
7. Advances in polyamide nanocomposites: A review10.1002/pc.24837 ↗
8. Design and synthesis of new s-triazine polymers and their application as nanoparticulate drug delivery systems10.1039/C6NJ02539K ↗
9. Biodegradable polymers in drug delivery and oral vaccination10.1016/j.eurpolymj.2020.110155 ↗
10. Polypeptides and polyaminoacids in drug delivery10.1517/17425247.2012.647906 ↗
11. Polyamide-based pH and temperature-responsive hydrogels: Synthesis and physicochemical characterization10.1007/s10965-018-1666-4 ↗
12. Patravale, V., Dandekar, P., and Jain, R. (2012). Clinical trials industrial aspects. Nanoparticulate Drug Delivery, Woodhead Publishing.10.1533/9781908818195 ↗
13. Simmons, P., McElroy, T., and Allen, A.R. (2020). A Bibliometric Review of Artificial Extracellular Matrices Based on Tissue Engineering Technology Literature: 1990 through 2019. Materials, 13.10.3390/ma13132891 ↗
14. Polymers as Biomaterials for Tissue Engineering and Controlled Drug Delivery
15. Small changes in polymer chemistry have a large effect on the bone–implant interface: Evaluation of a series of degradable tyrosine-derived polycarbonates in bone defects10.1016/S0142-9612(99)00151-9 ↗
16. Osteogenic Differentiation of Pre-Osteoblasts on Biomimetic Tyrosine-Derived Polycarbonate Scaffolds10.1021/bm200700d ↗
17. Poly(amino acid)s/polypeptides as potential functional and structural materials10.1038/pj.2015.35 ↗
18. Sol-gel production of bioactive nanocoatings for medical applications. Part II: Current research and development10.2217/17435889.2.1.51 ↗
19. Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release10.1021/acs.chemrev.5b00346 ↗
20. Poly(aspartic-acid) derivatives as polymeric micelle drug delivery systems10.1002/app.23353 ↗
21. PEG-g-poly(aspartamide-co-N,N-dimethylethylenediamino aspartamide): Synthesis, characterization and its application as a drug delivery system10.1016/j.pnsc.2009.02.008 ↗
22. Nanoparticles based on the complex of chitosan and polyaspartic acid sodium salt: Preparation, characterization and the use for 5-fluorouracil delivery10.1016/j.ejpb.2007.04.007 ↗
23. Conjugation of Arginine-Glycine-Aspartic Acid Peptides to Poly(ethylene oxide)-b-poly(ε-caprolactone) Micelles for Enhanced Intracellular Drug Delivery to Metastatic Tumor Cells10.1021/bm060967g ↗
24. Biodegradation of copoly(L-aspartic acid/L-glutamic acid) in vitro10.1002/bip.360290310 ↗
25. A Novel Biodegradable Green Poly(l-Aspartic Acid-Citric Acid) Copolymer for Antimicrobial Applications10.1007/s10924-011-0335-z ↗
26. pH-Responsive Self-Assembly and conformational transition of partially propyl-esterified poly(α,β-l-aspartic acid) as amphiphilic biodegradable polyanion10.1016/j.colsurfb.2008.08.026 ↗
27. Poly(aspartic acid): Synthesis, biodegradation, and current applications10.1007/BF02763661 ↗
28. PEG-poly(amino acid) Block Copolymer Micelles for Tunable Drug Release10.1007/s11095-010-0120-z ↗
29. Formulation and characterization of 5-Fluorouracil enteric coated nanoparticles for sustained and localized release in treating colorectal cancer10.1016/j.jsps.2014.11.010 ↗
30. Self-Propelled and Targeted Drug Delivery of Poly(aspartic acid)/Iron–Zinc Microrocket in the Stomach
31. Synthesis and Biodegradability of Polyaspartic Acid: A Critical Review10.1080/10601320500189604 ↗
32. Hydrogels Based on Poly(aspartic acid): Synthesis and Applications10.3389/fchem.2019.00755 ↗
33. Antimicrobial action of EPSILON-poly-L-lysine10.7164/antibiotics.37.1449 ↗
34. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system10.1016/S0021-9258(18)61209-8 ↗
35. Transfection of Folate-Polylysine DNA Complexes: Evidence for Lysosomal Delivery10.1021/bc00035a002 ↗
36. Transferrin-polycation-mediated introduction of DNA into human leukemic cells: Stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels10.1073/pnas.87.11.4033 ↗
37. Gene transfer in vivo: Sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake10.1073/pnas.91.9.4086 ↗
38. Polymers in drug delivery10.1016/S1367-5931(00)00227-1 ↗
39. Folate receptor mediated intracellular protein delivery using PLL–PEG–FOL conjugate10.1016/j.jconrel.2005.01.006 ↗
40. Target-Specific Cellular Uptake of PLGA Nanoparticles Coated with Poly(l-lysine)−Poly(ethylene glycol)−Folate Conjugate10.1021/la0502084 ↗
41. Preparation of poly-l-lysine-based nanoparticles with pH-sensitive release of curcumin for targeted imaging and therapy of liver cancer in vitro and in vivo10.1080/10717544.2018.1461957 ↗
42. Strategies on the nuclear-targeted delivery of genes10.3109/1061186X.2013.830310 ↗
43. Functions of poly-gamma-glutamic acid (γ-PGA) degradation genes in γ-PGA synthesis and cell morphology maintenance10.1007/s00253-014-5729-0 ↗
44. Poly(l-glutamic acid)–anticancer drug conjugates10.1016/S0169-409X(02)00045-5 ↗
45. Poly(glutamic Acid) for Biomedical Applications10.1080/07388550108984171 ↗
46. Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats10.1038/sj.bjc.6602772 ↗
47. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice
48. Mind the gap: A survey of how cancer drug carriers are susceptible to the gap between research and practice10.1016/j.jconrel.2013.09.026 ↗
49. A new class of polymerizable dextrans with hydrolyzable groups: Hydroxyethyl methacrylated dextran with and without oligolactate spacer10.1016/S0032-3861(97)00189-4 ↗
50. Paclitaxel-loaded poly(γ-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer10.1016/j.biomaterials.2005.10.027 ↗
51. Self-assembling chitosan/poly-γ-glutamic acid nanoparticles for targeted drug delivery10.1007/s00396-009-2022-3 ↗
52. FRET-based dual-emission and pH-responsive nanocarriers for enhanced delivery of protein across intestinal epithelial cell barrier10.1021/am505441p ↗
53. Enhancement of efficiency of chitosan-based complexes for gene transfection with poly(γ-glutamic acid) by augmenting their cellular uptake and intracellular unpackage10.1016/j.jconrel.2014.04.024 ↗
54. Anti-inflammatory Chitosan/Poly-γ-glutamic acid nanoparticles control inflammation while remodeling extracellular matrix in degenerated intervertebral disc10.1016/j.actbio.2016.06.013 ↗
55. Nanoencapsulation of red ginseng extracts using chitosan with polyglutamic acid or fucoidan for improving antithrombotic activities10.1021/acs.jafc.6b00911 ↗
56. Poly-γ-glutamic acid microneedles with a supporting structure design as a potential tool for transdermal delivery of insulin10.1016/j.actbio.2015.06.021 ↗
57. Yan, X., Tong, Z., Chen, Y., Mo, Y., Feng, H., Li, P., Qu, X., and Jin, S. (2017). Bioresponsive Materials for Drug Delivery Based on Carboxymethyl Chitosan/Poly(γ-Glutamic Acid) Composite Microparticles. Mar. Drugs, 15.10.3390/md15050127 ↗
58. Tekade, R.K. (2019). Chapter 4—Use of Polymers in Controlled Release of Active Agents. Basic Fundamentals of Drug Delivery, Academic Press.
59. Terminal chemical functions of polyamidoamine dendrimer surfaces and its impact on bone cell growth10.1016/j.msec.2019.03.073 ↗
60. Synthesis of a Novel Dendritic Liquid Crystalline Polymer Showing a Ferroelectric SmC* Phase10.1021/ja9813562 ↗
61. Homogeneous catalysts based on silane dendrimers functionalized with arylnickel(II) complexes10.1038/372659a0 ↗
62. Studies on Polyamidoamine Dendrimers as Efficient Gene Delivery Vector10.1177/0885328207080005 ↗
63. In Vitro Gene Delivery by Degraded Polyamidoamine Dendrimers10.1021/bc9600630 ↗
64. Synthesis of a novel water-soluble polyamide dendrimer based on a facile convergent method10.1016/j.eurpolymj.2009.04.013 ↗
65. Starburst Dendrimers—Molecular-Level Control of Size, Shape, Surface-Chemistry, Topology, and Flexibility from Atoms to Macroscopic Matter
66. PAMAM Dendrimer Based Macromolecules as Improved Contrast Agents10.1021/mp050019e ↗
67. Florendo, M., Figacz, A., Srinageshwar, B., Sharma, A., Swanson, D., Dunbar, G.L., and Rossignol, J. (2018). Use of Polyamidoamine Dendrimers in Brain Diseases. Molecules, 23.10.3390/molecules23092238 ↗
68. Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins10.1016/j.ijpharm.2005.07.023 ↗
69. Dendrimers: A class of polymers in the nanotechnology for the delivery of active pharmaceuticals10.2174/138161209789058200 ↗
70. Dendrimers as Carriers for Delivery of Chemotherapeutic Agents10.1021/cr900174j ↗
71. Supramolecular Dendritic Polymers: From Synthesis to Applications10.1021/ar500057e ↗
72. Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy10.1016/j.ijpharm.2018.05.045 ↗
73. Poly (amidoamine)(PAMAM): An emerging material for electrochemical bio (sensing) applications10.1016/j.talanta.2015.11.022 ↗
74. In vitro studies of phospholipid-modified PAMAM-siMDR1 complexes for the reversal of multidrug resistance in human breast cancer cells10.1016/j.ijpharm.2017.06.026 ↗
75. Fatty Acid Based Polyamide for Application in Drug Delivery System: Synthesis, Characterization, Drug Loading and In Vitro Drug Release Study10.1007/s10904-020-01512-x ↗
76. In vitro characterization of a synthetic polyamide-based erodible compact disc for extended drug release10.1007/s42452-020-03954-x ↗
77. 5-Phenyl-1,3,4-oxadiazole-2-thiol/polyamide-montmorillonite microbicides nanocomposites as drug delivery system10.1002/poc.3834 ↗
78. Clathrin-Independent Killing of Intracellular Mycobacteria and Biofilm Disruptions Using Synthetic Antimicrobial Polymers10.1021/acs.biomac.7b00106 ↗
79. Hesperetin-loaded lipid-core nanocapsules in polyamide: A new textile formulation for topical drug delivery10.2147/IJN.S124564 ↗
80. Multi-Layered Polyamide/Collagen Scaffolds with Topical Sustained Release of N-Acetylcysteine for Promoting Wound Healing10.2147/IJN.S232190 ↗
81. In Vitro Evaluation of a Targeted and Sustained Release System for Retinoblastoma Cells Using Doxorubicin as a Model Drug10.1089/jop.2010.0048 ↗
82. Polymer Architecture and Drug Delivery10.1007/s11095-005-9046-2 ↗
83. Progress of drug-loaded polymeric micelles into clinical studies10.1016/j.jconrel.2014.06.042 ↗
84. The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo10.1016/j.addr.2012.10.002 ↗
85. Block Copolymer Micelles in Nanomedicine Applications10.1021/acs.chemrev.8b00199 ↗
86. Taxol in the management of cancers of the breast and the ovary10.3109/07357900009031828 ↗
87. Multifunctional Nanomaterials and Their Applications in Drug Delivery and Cancer Therapy10.3390/nano5041690 ↗
88. Hypersensitivity reactions from taxol10.1200/JCO.1990.8.7.1263 ↗
89. Paclitaxel (taxol)10.1056/NEJM199504133321507 ↗
90. Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: Neuromuscular toxicity is dose-limiting10.1200/JCO.1993.11.10.2010 ↗
91. Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: An active regimen with limiting neurotoxicity10.1200/JCO.1996.14.7.1993 ↗
92. NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel10.1038/sj.bjc.6602479 ↗
93. Soluble polymers as carriers of cis-platinum10.1016/0168-3659(89)90019-9 ↗
94. Block copolymer micelles as vehicles for drug delivery10.1016/0168-3659(93)90172-2 ↗
95. Polymer micelles as novel drug carrier: Adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer10.1016/0168-3659(90)90139-K ↗
96. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood
97. Poly (amino acid) micelle nanocarriers in preclinical and clinical studies10.1016/j.addr.2007.11.010 ↗
98. NK105, a paclitaxel-incorporating micellar nanoparticle, is a more potent radiosensitising agent compared to free paclitaxel10.1038/sj.bjc.6603311 ↗
99. A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation10.1038/sj.bjc.6603855 ↗
100. Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer10.1007/s10637-011-9709-2 ↗